Abstract: An improved injector needle apparatus is described with inherent properties for increasing linear flow rates when inserted into a subcutaneous port during tissue expansion thus decreasing procedure time.
Type:
Grant
Filed:
March 10, 2016
Date of Patent:
October 8, 2019
Assignee:
Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company